According to Gram Research analysis, a traditional Chinese herbal formula called Qinggan Jianpi Formula significantly reduced atherosclerosis in laboratory and animal studies by changing how immune cells behave and reducing inflammation. The formula lowered blood lipids, reduced plaque buildup in arteries, and shifted immune cells from a damaging inflammatory state to a healing state through a mechanism involving lactate metabolism and gene activation. However, these findings come from laboratory and animal studies—human clinical trials are needed before this can be recommended as a treatment.

Researchers discovered how a traditional Chinese herbal medicine called Qinggan Jianpi Formula (QGJP) may help prevent and reverse atherosclerosis—the dangerous buildup of plaque in arteries. Using laboratory and animal studies, scientists found that the formula works by changing how immune cells behave, reducing inflammation, and lowering blood lipids. The herb appears to work through a complex biological mechanism involving how cells use energy and turn on repair genes. This research could lead to new treatments for heart disease, one of the world’s leading causes of death.

Key Statistics

A 2026 laboratory study identified 47 bioactive compounds in Qinggan Jianpi Formula and found that the formula significantly reduced blood lipids and plaque buildup in mice with atherosclerosis while shifting immune cells toward a repair-promoting phenotype.

Research reviewed by Gram found that three specific compounds from the herbal formula (SAA, LA, and CAB) effectively inhibited inflammatory immune cell polarization and activated repair-related genes in laboratory studies of atherosclerosis.

The 2026 study demonstrated that Qinggan Jianpi Formula reduced the expression of matrix metalloproteinases, adhesion molecules, and chemokines—key inflammatory factors that damage blood vessels and promote plaque formation.

The Quick Take

  • What they studied: How a traditional Chinese herbal formula affects atherosclerosis (clogged arteries) and the biological mechanisms that make it work
  • Who participated: Laboratory studies using mice genetically prone to atherosclerosis, human cells grown in dishes, and chemical analysis of the herbal formula’s ingredients
  • Key finding: The herbal formula reduced blood lipids, reduced plaque buildup, and changed how immune cells behave in ways that promote healing rather than inflammation
  • What it means for you: This research suggests a potential new approach to treating heart disease, though human clinical trials are needed before it can be recommended as a treatment. The findings are promising but preliminary.

The Research Details

This was a laboratory and animal research study published in 2026. Researchers first identified 47 active chemical compounds in the Qinggan Jianpi Formula using advanced chemical analysis. They then tested the formula in three ways: in mice fed a high-fat diet that naturally develop atherosclerosis, in human blood vessel cells exposed to damaged cholesterol, and in immune cells that turn into foam cells (a key part of plaque formation).

The researchers measured multiple outcomes including blood lipid levels, plaque size and composition, blood vessel function, and changes in immune cell behavior. They also studied the molecular mechanisms—essentially how the formula changes the activity of genes and proteins inside cells.

Three specific compounds from the formula (SAA, LA, and CAB) were tested individually to confirm they had the same beneficial effects as the whole formula.

This research approach is important because it bridges traditional medicine and modern science. Rather than just testing whether something works, the researchers identified exactly how it works at the cellular and molecular level. This makes it possible to develop better treatments and understand which patients might benefit most. The combination of animal studies, cell studies, and chemical analysis provides multiple lines of evidence supporting the findings.

Strengths: The study used multiple complementary research methods (animal models, cell cultures, and chemical analysis), identified specific active compounds, and tested mechanisms at multiple biological levels. Limitations: This research was conducted in laboratory and animal settings, not in humans. Results in mice don’t always translate to humans. The study doesn’t specify exact sample sizes for all experiments. Human clinical trials would be needed to confirm these findings apply to people.

What the Results Show

The herbal formula significantly reduced blood lipid levels in mice with atherosclerosis, similar to what you’d see with cholesterol-lowering medications. It also reduced the size of plaques in arteries and changed their composition—making them more stable and less likely to rupture.

The formula improved how blood vessel cells function and reduced their ability to stick to immune cells, which is a key step in plaque formation. It also reduced the production of inflammatory molecules that damage blood vessels.

Most importantly, the formula changed how immune cells behave. Normally in atherosclerosis, immune cells called macrophages become “M1” type cells that promote inflammation and damage. The formula shifted them toward “M2” type cells that promote healing and repair. This shift appears to be the main mechanism behind the formula’s benefits.

The researchers identified that the formula works by reducing how much lactate (a byproduct of energy metabolism) immune cells produce and transport. This change triggers a cascade of molecular events that activates repair genes in macrophages.

The formula reduced the expression of matrix metalloproteinases (enzymes that break down blood vessel structure), adhesion molecules (that help cells stick together in harmful ways), and chemokines (signaling molecules that recruit inflammatory cells). These changes all contribute to stabilizing plaques and reducing inflammation. The formula also enhanced the ability of blood vessel cells to migrate and repair themselves. Three specific compounds in the formula—SAA, LA, and CAB—were shown to produce these same beneficial effects when tested individually.

This research adds to growing evidence that traditional Chinese herbal formulas may have measurable effects on cardiovascular disease through multiple biological pathways. Previous research has shown that various herbs can affect cholesterol and inflammation, but this study provides more detailed mechanistic understanding. The focus on macrophage polarization and metabolic reprogramming represents a newer approach to understanding how these formulas work. The findings align with modern understanding that atherosclerosis involves not just lipid accumulation but also immune dysfunction and inflammation.

This study was conducted entirely in laboratory and animal models—not in humans. Mice don’t always respond the same way humans do to treatments. The study doesn’t provide information about dosing, safety, side effects, or how long treatment would need to continue. It’s unclear whether the benefits seen in mice would occur in people. The formula contains 47 different compounds, making it difficult to know which ones are most important. Human clinical trials would be necessary before this could be recommended as a medical treatment.

The Bottom Line

Based on this research alone, the herbal formula cannot be recommended as a treatment for atherosclerosis in humans. The evidence is promising but preliminary (confidence level: low to moderate). This research should encourage further human studies. People with atherosclerosis or high cholesterol should continue following their doctor’s recommendations for proven treatments like statins, diet changes, and exercise. This research may eventually lead to new treatment options, but that’s years away.

This research is most relevant to: cardiovascular researchers and drug developers looking for new treatment approaches; people interested in how traditional medicine works at a molecular level; patients with atherosclerosis or high cholesterol who want to understand emerging research. This research should NOT be used by patients to replace proven medical treatments. People with heart disease should not stop taking prescribed medications based on this study.

If this research leads to human clinical trials, it would typically take 5-10 years to determine whether the formula is safe and effective in people. Even if successful in trials, regulatory approval and availability would take additional time. This is very early-stage research.

Frequently Asked Questions

Can I use this Chinese herbal formula to treat my high cholesterol or heart disease?

Not yet. While laboratory studies show promise, human clinical trials haven’t been conducted. Continue taking prescribed medications and following your doctor’s recommendations. This research may eventually lead to new treatments, but that requires years of additional testing in people.

How does Qinggan Jianpi Formula work to reduce atherosclerosis?

The formula appears to work by reducing how immune cells produce lactate (an energy byproduct) and changing their behavior from inflammatory to repair-promoting. This shift reduces plaque formation, lowers blood lipids, and helps blood vessels heal. The mechanism involves activating repair genes through a process called histone lactylation.

Is this research applicable to humans or just animals?

This research was conducted in mice and laboratory cell cultures, not humans. While the findings are encouraging, results in animals don’t always translate to people. Human clinical trials would be necessary to determine if the formula is safe and effective in patients with atherosclerosis.

What are the main limitations of this study?

The study was conducted only in laboratory and animal models, not humans. It doesn’t provide information about dosing, safety, side effects, or long-term use in people. The formula contains 47 compounds, making it unclear which are most important. Human trials are needed before clinical recommendations can be made.

When might this herbal formula become available as a treatment?

If human clinical trials are initiated soon, it would typically take 5-10 years to establish safety and effectiveness. Regulatory approval and availability would take additional time. This is very early-stage research, so widespread availability is likely many years away.

Want to Apply This Research?

  • Track lipid levels (cholesterol and triglycerides) through regular blood tests every 3-6 months, recording the specific values. Also track cardiovascular symptoms like chest discomfort, shortness of breath, or unusual fatigue.
  • While this specific formula isn’t yet available as a treatment, users can track evidence-based atherosclerosis prevention: daily steps walked, servings of vegetables consumed, alcohol intake, and adherence to prescribed medications. These proven interventions address the same biological pathways.
  • Establish a baseline of current lipid levels and cardiovascular health markers. Set quarterly check-ins with healthcare providers for blood work. Track lifestyle factors that influence atherosclerosis risk (diet quality, exercise, stress, sleep). Monitor for any new symptoms. Compare trends over 6-12 months to see if interventions are working.

This article describes laboratory and animal research that has not been tested in humans. The findings are preliminary and should not be used to guide medical decisions. Qinggan Jianpi Formula is not approved by the FDA for treating atherosclerosis or any other condition in the United States. People with atherosclerosis, high cholesterol, or heart disease should continue following their doctor’s recommendations and taking prescribed medications. Do not stop or replace prescribed treatments based on this research. Consult with your healthcare provider before starting any new supplements or herbal products, as they may interact with medications or have side effects. This research may eventually lead to new treatments, but human clinical trials are necessary before any recommendations can be made.

This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.

Source: Qinggan Jianpi formula attenuates atherosclerosis by suppressing macrophage lactate transport to activate repair genes via H3K18 lactylation.Chinese medicine (2026). PubMed 42032694 | DOI